Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus (RSV)

Latest Posts

  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
HEPA purifiers not tied to less viral exposure in elementary classrooms, analysis finds​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Data: Pediatric hospital strain amid 2022-23 respiratory virus season not tied to decline in beds​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Cochrane review shows RSV vaccines safe, effective​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Trial finds clesrovimab 60% effective in preventing RSV in infants​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Study highlights elevated rates of hospitalization, ICU care, death in older RSV patients​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Report: Kids with severe RSV at higher risk for hospitalization than those with HMPV​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
New ACC guidance urges uptake of 5 vaccines for heart patients​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Researchers note high burden of RSV on older US adults before vaccine availability​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Vaccine Integrity Project presents reassuring data on vaccines for upcoming respiratory virus season​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Timing of maternal vaccination, nirsevimab to avert RSV in infants may influence cost-effectiveness​
Load More
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Medical societies recommend RSV vaccines for older or immune-compromised adults​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Up to 56,000 people died from COVID-19 or RSV last year​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Rapid RSV tests linked to less antibiotic prescribing in kids​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Up to 56,000 people died from COVID-19 or RSV last year​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
US flu activity still high, with 8 more pediatric deaths​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
In 2023-24, RSV vaccines were 79% effective against virus-related blood clots in older adults, CDC estimates​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
CDC reports 6 more child deaths from flu, as virus levels stay moderate to high​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Study ties adult RSV hospitalization to a higher risk of heart and lung problems in next 6 months​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Analysis suggests nirsevimab cuts infant RSV hospitalizations 83%​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Most Americans would recommend RSV immunizations for older adults, infants, pregnant women​